Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Farmers Insurance
Fish and Richardson
Argus Health

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018074

« Back to Dashboard

NDA 018074 describes PHENDIMETRAZINE TARTRATE, which is a drug marketed by Graham Dm, Sandoz, Vitarine, Barr, Chartwell Rx, Elite Labs Inc, Ferndale Labs, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Mikart, Nexgen Pharma Inc, Numark, Pvt Form, Solvay, Usl Pharma, and Watson Labs, and is included in sixty-five NDAs. It is available from twenty-three suppliers. Additional details are available on the PHENDIMETRAZINE TARTRATE profile page.

The generic ingredient in PHENDIMETRAZINE TARTRATE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
Summary for 018074
Ingredient:phendimetrazine tartrate
Formulation / Manufacturing:see details
Pharmacology for NDA: 018074
Suppliers and Packaging for NDA: 018074
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHENDIMETRAZINE TARTRATE phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 018074 NDA Eon Labs, Inc. 0185-5254 N 0185-5254-10
PHENDIMETRAZINE TARTRATE phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 018074 NDA Eon Labs, Inc. 0185-5254 N 0185-5254-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength105MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.